MARK2 and cancer: Mechanistically, the pyrazole derivatives function through molecular mechanisms that target multiple cancer cell signaling molecules, including EGFR (epidermal growth factor receptor), BRAF V600E (B-Raf proto-oncogene, serine/threonine kinase), telomerase, Aurora-A kinase, and multiple receptor tyrosine kinases.